AI for cardiometabolic health:novel strategies for prevention and careCHEN Wen-jia, SHI Jing, LI Yue, FU Yu893-898
Diet-Gut microbiota axis:a new perspective on the intervention of cardiovascular metabolic diseasesWU Yuan-jing, BAI Ming, WU Yue899-903
Risk screening and interventional management of cardiometabolic diseases related to visceral adiposityLIU Jing, KONG Xiang-qing910-912
Current status and prospects of clinical diagnosis and management of salt sensitive hypertensionMA Zhi-yi913-916,926
Exercise for cardiometabolic diseases:multi-target and comprehensive pathway benefitsZHOU Le-qun, SHEN Tao, TANG Yi-da917-920
Emerging insights into the interplay between dyslipidemia and cardiometabolic diseases:mechanisms and therapeutic strategiesMA Run-ze, QUAN Nan-hu921-926
Study on the correlation of serum monoamine oxidase and inflammatory markers with the severity of coronary artery lesionsZHAO Xiao-tong, CAO Qian952-956
Study on the correlation between ketosis episodes and risk of atherosclerosis in patients with newly-onset ketosis-prone type 2 diabetesZHU Hai-wei, LIANG Lin-lang, YU Hao, WANG Yu, LI Yu-jie957-961
Clinical features and etiological analysis of 195 patients with pyogenic liver abscessJIN Chao, DONG Guo-zhen, LI Xiao-ting, LIU Hong-yu, SU Man, LI Ji-jiao, WEI Yan-chun, WANG Ke-shan, CAI Cai-lian, JIANG Jian-ning, SU Ming-hua962-968
